» Articles » PMID: 23015224

Preoperative Assessment of Tumor Location and Station-specific Lymph Node Status in Patients with Adenocarcinoma of the Gastroesophageal Junction

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2012 Sep 28
PMID 23015224
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In esophageal cancer patients preoperative staging will determine the type of surgical procedure and use of neoadjuvant therapy. Tumor location and lymph node status play a pivotal role in this tailored strategy. The aim of the present study was to prospectively evaluate the accuracy of preoperative assessment of tumor location according to the Siewert classification and lymph node status per station with endoscopy/endoscopic ultrasound (EUS) and computed tomography (CT).

Methods: In 50 esophagectomy patients with adenocarcinoma of the gastroesophageal junction (GEJ), tumor location according to Siewert and N-stage per nodal station as determined preoperatively by endoscopy/EUS and CT were compared with the histopathologic findings in the resection specimen.

Results: Overall accuracy in predicting tumor location according to the Siewert classification was 70 % for endoscopy/EUS and 72 % for CT. Preoperative data could not be compared with the pathologic assessment in 11 patients (22 %), as large tumors obscured the landmark of the gastric folds. The overall accuracy for predicting the N-stage in 250 lymph node stations was 66 % for EUS and 68 % for CT. The accuracy was good for those stations located high in the thorax, but poor for celiac trunk nodes.

Conclusions: Given the frequent discrepancy between the endoscopic and pathologic location of the GEJ and the common problem of advanced tumors obscuring the landmarks used in the assessment of the Siewert classification, its usefulness is limited. The overall accuracy for EUS and CT in predicting the N-stage per station was moderate.

Citing Articles

Oncologic Outcome of Patients With Pathologic T0 Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.

Chen S, Wang X, Chen Y Cancer Control. 2024; 31:10732748241284905.

PMID: 39259832 PMC: 11406660. DOI: 10.1177/10732748241284905.


The Multidisciplinary Approach and Surgical Management of GE Junction Adenocarcinoma.

Oberoi M, Noor M, Abdelfatah E Cancers (Basel). 2024; 16(2).

PMID: 38254779 PMC: 10813924. DOI: 10.3390/cancers16020288.


The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet-ring cells, and/or poorly cohesive cells.

Valkema M, Vos A, van der Post R, Ooms A, Oudijk L, Eyck B J Pathol Clin Res. 2023; 9(4):322-335.

PMID: 36971406 PMC: 10240149. DOI: 10.1002/cjp2.321.


Gross tumor volume of adenocarcinoma of esophagogastric junction corresponding to cT and cN stages measured with computed tomography to quantitatively determine resectabiliy: A case control study.

Li K, Ou J, Zhou H, Yu Z, Gao D, You X Front Oncol. 2022; 12:1038135.

PMID: 36465362 PMC: 9714446. DOI: 10.3389/fonc.2022.1038135.


Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.

Lin X, Li Z, Tan C, Ye X, Xiong J, Liu J Front Oncol. 2021; 11:748694.

PMID: 34926257 PMC: 8672940. DOI: 10.3389/fonc.2021.748694.


References
1.
Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I . Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg. 2006; 202(4):604-11. DOI: 10.1016/j.jamcollsurg.2005.12.004. View

2.
Umeoka S, Koyama T, Togashi K, Saga T, Watanabe G, Shimada Y . Esophageal cancer: evaluation with triple-phase dynamic CT--initial experience. Radiology. 2006; 239(3):777-83. DOI: 10.1148/radiol.2393050222. View

3.
Chandrasoma P, Makarewicz K, Wickramasinghe K, Ma Y, DeMeester T . A proposal for a new validated histological definition of the gastroesophageal junction. Hum Pathol. 2005; 37(1):40-7. DOI: 10.1016/j.humpath.2005.09.019. View

4.
Ringhofer C, Lenglinger J, Eisler M, Wrba F, Sedivy R, Zacherl J . Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr. 2007; 119(9-10):283-90. DOI: 10.1007/s00508-007-0786-3. View

5.
Rosch T . Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am. 1995; 5(3):537-47. View